Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome

NLRP3 inflammasome is a novel therapeutic target for inflammatory bowel disease (IBD). The aim of this study was to investigate the anti-inflammatory effect of a bioactive flavonoid—oroxylin A on the treatment of dextran sulfate sodium (DSS)-induced murine colitis via targeting NLRP3 inflammasome. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wei, Liu, Xiuting, Zhang, Xin, Tang, Jingjing, Li, Zhiyu, Wang, Qing, Hu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601702/
https://www.ncbi.nlm.nih.gov/pubmed/28938606
http://dx.doi.org/10.18632/oncotarget.19440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601702/
https://www.ncbi.nlm.nih.gov/pubmed/28938606
http://dx.doi.org/10.18632/oncotarget.19440

Ejemplares similares